Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio Technology General - BTGC -- Ignore unavailable to you. Want to Upgrade?

To: Dave O. who wrote (1997)	4/6/2000 8:07:00 AM
From: blackmerlin	Respond to of 2028

BTGC Rebound: At least 3 Biotech/Medtech stocks under $30/sh. have rebounded above their monthly close (see biobiznet.com). These are BCHE 22 5/8, BTGC 16, GENE 23 3/4. Many other bio/med stocks are edging up from Tuesday's big dip. This is a good sign. Under $30 BioMed Index is now at 91% of it's monthly close (http://www.biobiznet.com). The Long Run is Best-If we can resist selling on dips or cover margin calls from cash if we can, biotechs may pull through OK. Regards, Jake Blackmerlin